CALGARY, Alberta, March 10, 2010 (GLOBE NEWSWIRE) -- Liberty Analytics Co., a leading provider of large, small- and micro-cap independent investment research, today initiated coverage on Star Scientific, Inc. (Nasdaq:CIGX). Liberty Analytics is currently offering a complimentary trial subscription. To view our research, go to: www.libertyanalyticsco.com
About LAC:
Liberty Analytics Co. is a leading provider of independent investment research in North America. Our services include research analysis on the large, small- and micro-cap markets, real-time news and financial data, market commentary and the LAC newsletter. Liberty Analytics' staff of large and small-cap investment professionals is dedicated to providing the market's investment community with the tools and avenues necessary to make the important investment decisions. To view our research reports on a complimentary trial basis and take advantage of our other services, go to www.libertyanalyticsco.com and click on the complimentary trial subscription button on our home page, or go directly to our registration page at www.libertyanalyticsco.com/signup.php
About Star Scientific, Inc. (Nasdaq:CIGX)
Star Scientific, Inc. (Nasdaq:CIGX) is a tobacco company that focuses on reducing toxins in tobacco leaf and tobacco smoke. The Company is primarily engaged in the development, implementation and licensing of its technology for the curing of tobacco to prevent the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the tobacco-specific nitrosamines (TSNAs); the manufacture, sales, marketing and development of very low-TSNA dissolvable smokeless tobacco products, including ARIVA compressed powdered tobacco cigalett pieces and STONEWALL Hard Snuff; and the licensing of trademarks for certain of its cigarette brands.
LAC Disclosure:
Libertyanalyticsco.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Liberty Analytics has not been compensated by any of the above-mentioned companies. Please read our report and visit our Web site, www.libertyanalyticsco.com, for complete risks and disclosures.